Immuto Scientific, Inc. is a contract research organization that provides analytical research services for drug discovery. Immuto Scientific's mission is to enable the discovery of lifesaving therapeutics against undruggable targets to treat diseases such as cancer. Immuto's patented technology, called Plasma-Induced Modification of Biomolecules (“PLIMB”), helps solve a fundamental problem in drug discovery – understanding how effectively a drug binds to its target which helps improve it.